Peter H. Calcott, VP, Quality & Compliance at PDL BIOPHARMA, INC. (PDLI), sold 439 shares at $18.44 ($8K) on 2006-07-05, disclosed to the SEC on 2006-07-07.
Scheduled sale ($8k) by VP, Quality & Compliance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |